Literature DB >> 6130707

Central injection of angiotensin II alters catecholamine activity in rat brain.

C Sumners, M I Phillips.   

Abstract

Centrally injected angiotensin II (ANG II) produces a pressor response. The effect of ANG II injected intracerebroventricularly on catecholamine utilization in specific rat brain regions was examined. A pressor dose of ANG II stimulated an increase in norepinephrine (NE) utilization in the locus coeruleus, raphe magnus and AI regions of the brain stem, and in the hypothalamus. These increases in NE utilization were selective, and dopamine utilization was not altered in the same regions. Also, the changes in NE utilization were direct and not due to the rise in blood pressure caused by ANG II, since a similar pressor effect caused by intravenously injected hypertonic saline did not alter NE utilization in any of the above regions. Areas such as the subfornical organ and organum vasculosum of the lamina terminalis that contain both catecholamines and ANG II receptors did not show a substantial change in catecholamine utilization after intracerebroventricularly injected ANG II. This study demonstrates that specific brain NE rich regions are activated by intracerebroventricular injection of ANG II. Some of these regions correlate with known blood pressure control centers and the data points to brain catecholaminergic regions which are involved in the central ANG II pressor response.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130707     DOI: 10.1152/ajpregu.1983.244.2.R257

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Effect of central RAS on one-kidney Grollman hypertension in rats and its mechanism.

Authors:  X Y Sheng; Q Wang; K Yang
Journal:  J Tongji Med Univ       Date:  1991

Review 2.  Hypothalamic and inflammatory basis of hypertension.

Authors:  Sinan Khor; Dongsheng Cai
Journal:  Clin Sci (Lond)       Date:  2017-02-01       Impact factor: 6.124

Review 3.  Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.

Authors:  Shereeni J Veerasingham; Mohan K Raizada
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

4.  Angiotensin II as a factor inhibiting the fear response.

Authors:  K V Sudakov
Journal:  Neurosci Behav Physiol       Date:  1987 Jan-Feb

5.  Selective local action of angiotensin II on dopaminergic neurons in the rat hypothalamus in vivo.

Authors:  E Badoer; H Würth; D Türck; F Qadri; K Itoi; P Dominiak; T Unger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

6.  Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats.

Authors:  Donglin Zhu; Jingping Shi; Yingdong Zhang; Bianrong Wang; Wei Liu; Zhicong Chen; Qiang Tong
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

Review 7.  The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.

Authors:  Hakuo Takahashi; Masamichi Yoshika; Yutaka Komiyama; Masato Nishimura
Journal:  Hypertens Res       Date:  2011-08-04       Impact factor: 3.872

8.  The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.

Authors:  Ashley J Porter; Katharine Pillidge; Ewelina M Grabowska; S Clare Stanford
Journal:  Eur Neuropsychopharmacol       Date:  2015-02-07       Impact factor: 4.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.